Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Synta Pharmaceutical (SNTA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 37,330
  • Shares Outstanding, K 137,810
  • Annual Sales, $ 0 K
  • Annual Income, $ -68,670 K
  • 36-Month Beta 1.06
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.90
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.26
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 08/04/16
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.25 +36.00%
on 07/20/16
0.40 -15.00%
on 07/22/16
+0.03 (+9.68%)
since 06/22/16
3-Month
0.25 +36.00%
on 07/20/16
0.45 -24.44%
on 05/13/16
-0.03 (-8.11%)
since 04/22/16
52-Week
0.15 +126.67%
on 02/08/16
2.23 -84.75%
on 08/11/15
-1.80 (-84.11%)
since 07/22/15

Most Recent Stories

More News
Anne Whitaker Named CEO of KNOW Bio Respiratory Company

KNOW Bio, LLC, a company created in late 2015 from the separation of all non- dermatological assets from Novan, Inc (NASDAQ: NOVN), announces the hiring of Anne Clem Whitaker as CEO of its Respiratory...

MDGL : 15.59 (+0.78%)
NOVN : 4.05 (+1.50%)
SNTA : 0.34 (+25.93%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend.

See More

Business Summary

SYNTA PHARMACEUTICALS CORP. is a biopharmaceutical company focused on discovering, developing, and commercializing small molecule drugs to extend and enhance the lives of patients with severe medical conditions, including cancer and chronic inflammatory diseases. Synta has a unique chemical compound...

See More

Support & Resistance

2nd Resistance Point 0.47
1st Resistance Point 0.40
Last Price 0.34
1st Support Level 0.27
2nd Support Level 0.21

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.